{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:24:47Z","timestamp":1791221087546,"version":"4.1.0"},"reference-count":37,"publisher":"Wiley","issue":"s127","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["APMIS"],"published-print":{"date-parts":[[2009,6]]},"abstract":"<jats:p>Because of their multiple overlapping clinical characteristics, Wegener's granulomatosis (WG) and microscopic polyangiitis (MPA) have increasingly been conceptualized as different expressions of a unique anti\u2010neutrophil cytoplasm antibodies (ANCA)\u2010associated vasculitis (AAV) disease spectrum. However, this continuum theory remains hindered by uncertainty surrounding a potentially common etiology. This review sheds light on our current understanding of the epidemiology of WG and MPA with the aim of weighing the evidence supporting whether or not these two vasculitis forms are distinct diseases. At present, some epidemiological evidence exists that WG and MPA might correspond to mere variants of a single AAV entity.<\/jats:p>","DOI":"10.1111\/j.1600-0463.2009.02476.x","type":"journal-article","created":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T07:22:14Z","timestamp":1243840934000},"page":"41-47","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Epidemiological features of Wegener's granulomatosis and microscopic polyangiitis: two diseases or one \u2018anti\u2010neutrophil cytoplasm antibodies\u2010associated vasculitis\u2019 entity?"],"prefix":"10.1111","volume":"117","author":[{"given":"ALFRED D.","family":"MAHR","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,6]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V82314"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780370206"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp048338"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/40.5.492"},{"key":"e_1_2_7_6_2","first-page":"83","article-title":"Predicting mortality in systemic Wegener's granulomatosis","volume":"51","author":"Bligny D","year":"2004","journal-title":"a survival analysis based on 93 patients"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330807"},{"key":"e_1_2_7_8_2","first-page":"388","article-title":"The epidemiology of the primary systemic vasculitides in northwest Spain","volume":"49","author":"Gonzalez\u2010Gay MA","year":"2003","journal-title":"implications of the Chapel Hill Consensus Conference definitions"},{"key":"e_1_2_7_9_2","first-page":"414","article-title":"Epidemiology of systemic vasculitis","volume":"43","author":"Watts RA","year":"2000","journal-title":"a ten-year study in the United Kingdom"},{"key":"e_1_2_7_10_2","first-page":"92","article-title":"Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg\u2013Strauss syndrome in a French urban multiethnic population in 2000","volume":"51","author":"Mahr A","year":"2004","journal-title":"a capture\u2013recapture estimate"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem107"},{"key":"e_1_2_7_12_2","first-page":"93","article-title":"Stable incidence of primary systemic vasculitides over five years","volume":"53","author":"Reinhold\u2010Keller E","year":"2005","journal-title":"results from the German vasculitis register"},{"key":"e_1_2_7_13_2","first-page":"1396","article-title":"Giant cell arteritis is more prevalent in urban than in rural populations","volume":"39","author":"Reinhold\u2010Keller E","year":"2000","journal-title":"results of an epidemiological study of primary systemic vasculitides in Germany"},{"key":"e_1_2_7_14_2","first-page":"28","article-title":"Epidemiology of systemic vasculitis","volume":"25","author":"Watts RA","year":"1995","journal-title":"changing incidence or definition?"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.60.12.1156a"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2008.01672.x"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kei259"},{"key":"e_1_2_7_18_2","first-page":"S648","article-title":"Case control study of ANCA\u2010associated vasculitis in Western Montana [abstract]","volume":"52","author":"Zeft A","year":"2005","journal-title":"Arthritis Rheum"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn354"},{"key":"e_1_2_7_20_2","first-page":"723","article-title":"Clinical [corrected] and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibody associated systemic vasculitides","volume":"81","author":"Chen M","year":"2005","journal-title":"a study of 426 patients from a single centre"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1381.042"},{"key":"e_1_2_7_22_2","first-page":"2060","article-title":"Increasing incidence of Wegener's granulomatosis in Sweden, 1975\u20132001","volume":"33","author":"Knight A","year":"2006","journal-title":"J Rheumatol"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200011)43:11<2481::AID-ANR15>3.0.CO;2-6"},{"key":"e_1_2_7_24_2","first-page":"S81","article-title":"Incidence of Wegener's granulomatosis in Finland 1981\u20132000","volume":"26","author":"Takala JH","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_7_25_2","first-page":"S82","article-title":"Epidemiology of Wegener's granulomatosis","volume":"24","author":"Mahr AD","year":"2006","journal-title":"lessons from descriptive studies and analyses of genetic and environmental risk determinants"},{"key":"e_1_2_7_26_2","first-page":"1299","article-title":"Outcome and prognostic factors during the course of primary small\u2010vessel vasculitides","volume":"33","author":"Pavone L","year":"2006","journal-title":"J Rheumatol"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(00)70288-5"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(99)70371-9"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.23157"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1006\/clim.1999.4811"},{"key":"e_1_2_7_31_2","first-page":"206","article-title":"Alpha\u20101\u2010antitrypsin phenotyping in ANCA\u2010associated diseases","volume":"14","author":"Esnault VL","year":"1997","journal-title":"one of several arguments for protease\/antiprotease imbalance in systemic vasculitis"},{"key":"e_1_2_7_32_2","first-page":"1961","article-title":"Occupational exposure in ANCA\u2010positive patients","volume":"67","author":"Beaudreuil S","year":"2005","journal-title":"a case\u2013control study"},{"key":"e_1_2_7_33_2","first-page":"290","article-title":"Association of silica exposure with anti\u2010neutrophil cytoplasmic autoantibody small\u2010vessel vasculitis","volume":"2","author":"Hogan SL","year":"2007","journal-title":"a population-based, case\u2013control study"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10830"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-120-1-199401010-00003"},{"key":"e_1_2_7_36_2","first-page":"405","article-title":"Drug\u2010associated antineutrophil cytoplasmic antibody\u2010positive vasculitis","volume":"43","author":"Choi HK","year":"2000","journal-title":"prevalence among patients with high titers of antimyeloperoxidase antibodies"},{"key":"e_1_2_7_37_2","first-page":"3508","article-title":"Association between thyroid disease and its treatment with ANCA small\u2010vessel vasculitis","volume":"22","author":"Lionaki S","year":"2007","journal-title":"a case\u2013control study"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021383"}],"container-title":["APMIS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0463.2009.02476.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0463.2009.02476.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T17:28:30Z","timestamp":1694626110000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0463.2009.02476.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":37,"journal-issue":{"issue":"s127","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["10.1111\/j.1600-0463.2009.02476.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0463.2009.02476.x","archive":["Portico"],"relation":{},"ISSN":["0903-4641","1600-0463"],"issn-type":[{"value":"0903-4641","type":"print"},{"value":"1600-0463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6]]},"assertion":[{"value":"2009-06-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}